$11.84
-0.71-5.66%
Last update: 3:24 PM
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
05/10/2024 | NVAX | Novavax | FY | 2024 | — | — | — | $400.00M | $600.00M | $845.49M | Get Alert |
02/28/2024 | NVAX | Novavax | Q1 | 2024 | — | — | — | $100.00M | $100.00M | $292.33M | Get Alert |
02/28/2024 | NVAX | Novavax | FY | 2024 | — | — | — | $800.00M | $1.00B | $969.56M | Get Alert |
11/09/2023 | NVAX | Novavax | FY | 2023 | — | — | — | $900.00M | $1.10B | $1.35B | Get Alert |
11/09/2023 | NVAX | Novavax | Q1 | 2024 | — | — | — | $300.00M | $300.00M | $648.29M | Get Alert |
08/08/2023 | NVAX | Novavax | FY | 2023 | — | — | — | $1.30B | $1.50B | $1.44B | Get Alert |
05/09/2023 | NVAX | Novavax | FY | 2023 | — | — | — | $1.40B | $1.60B | $831.60M | Get Alert |
12/14/2022 | NVAX | Novavax | FY | 2022 | — | — | — | $2.00B | $2.00B | $2.01B | Get Alert |
11/08/2022 | NVAX | Novavax | FY | 2022 | — | — | — | $2.00B | $2.00B | $2.04B | Get Alert |
08/08/2022 | NVAX | Novavax | FY | 2022 | — | — | — | $2.00B | $2.30B | $4.27B | Get Alert |
05/09/2022 | NVAX | Novavax | FY | 2022 | — | — | — | $4.00B | $5.00B | $4.49B | Get Alert |
02/28/2022 | NVAX | Novavax | FY | 2022 | — | — | — | $4.00B | $5.00B | $4.70B | Get Alert |
There have been no specific sales or earnings guidance reported for Novavax in recent months.
Browse guidance and forecast on all stocks.